The anticipation of the vaccine evaluation process “is excellent news”



[ad_1]

OR The prime minister considered “excellent news” the fact that the European Medicines Agency anticipated from 29 to 21 December Pfizer’s Vaccine Evaluation ProcessBioNTechHowever, without commenting on whether this anticipation could cause vaccination plans to begin later this year, earlier than planned.

“We are all making a great effort to coordinate so that, on the same day, in all Member States we can start the vaccination plan”, Reiterated António Costa, praising the role of the European Commission “to ensure the joint purchase.”

“It is an excellent demonstration of the added value that the EU constitutes, the guarantee that all citizens of Europe, regardless of their state, bigger or smaller, richer or poorer, from the North, the South, the East or the East. The West, they will have access to the vaccine at the same time, “the executive director said, speaking to reporters after a meeting with Macron in Paris.

It should be remembered that António Costa mentioned last week, outside the European Council, that the 5 of janeiro it would be a “great day “to start the vaccination process.

This Wednesday, the president of the European Commission, Ursula of the Read, I had already left the guarantee that “All Member States will start vaccination on the same day”.

The statement was made during a debate in the European Parliament during last week’s EU leaders’ summit. Ursula of the Read stressed that “no one should think they are safe [da pandemia], not when more than 3,000 Europeans die of COVID-19-19 every day ”, this, although there is“ finally good news ”.

The president of the European Commission referred to the existence of several vaccines, with “the European Commission negotiated the broadest portfolio of candidate vaccines”, no less than six.

The official recalled that the first vaccine must be authorized within a few days, after the European Medicines Agency (EMA) announced the day before that it anticipated the meeting to make a decision on Pfizer-BioNTech for 21 of December, a week earlier than expected.

In this way, the official urged the European Union to start “as soon as possible” a vaccination campaign against COVID-19-19, stressing that it should start simultaneousaneo in the 27 Member States, to ensure the eradication of the “horrible virus”.

EMA anticipates approval. Pressure from Germany?

The entity, which regulates the approval of medicines in the European Union, had scheduled the meeting for 29 December, but decided to anticipate justifying that he did so after receiving additional information about the vaccine from the laboratories that produce it.

The anticipation of the meeting date comes, however, after German Health Minister Jens Spahn, lobbied the European regulator to speed up the approval of the vaccine.

The minister considered the situation “especially irritating” because the use of the vaccine developed by BioNTech, from Germany, and the North American pharmaceutical company Pfizer has been authorized in countries such as the United Kingdom, the United States or Canada, but is still pending approval from the European Medicines Agency and therefore cannot be used in Germany or in any of the 27 EU countries.

This Tuesday, Jens Spahn increased pressure, joining a leading association of hospitals and legislators to demand that the agency approve a vaccine against coronavirus before Christmas.

“Ours objective It is that there is an approval before Christmas so that we can still start vaccinating this year, ”said the minister.

“A vaccine that was developed in Germany cannot be approved and administered (in the country) only in janeiro“, reinforced the federal deputy of the Free Democratic Party, Christine AschenbergBackground.

The German Hospital Association also issued a statement today, demanding that the European Union shorten the lengthy approval process and issue an emergency authorization for Pfizer-BioNTech.

Always be the first to know.
Follow the chosen site for the fourth consecutive year Consumer Choice.
Download our free app.

Download Apple Store
Download from Google Play



[ad_2]